National Health (Pharmaceutical Benefits—Early Supply) Specification 2026
7Circumstances relating to specification of pharmaceutical items in Schedule 1
Start here
Get a plain-English read of 7
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits—Early Supply) Specification 2026.
7 Circumstances relating to specification of pharmaceutical items in Schedule 1
For paragraph 6(2)(b), the circumstances in relation to a pharmaceutical benefit are:
(a) the supply of the benefit is made:
(i) on the basis of a prescription; or
(ii) to a person by an approved pharmacist under subsection 89A(1) of the Act; and
(b) if the pharmaceutical benefit is supplied as referred to in subparagraph (a)(i)—the prescription must have been written:
(i) for a purpose for which the maximum quantity or number of units specified in the column headed ‘Maximum quantity or number of units’ in an item in Schedule 1 for the pharmaceutical item was determined under paragraph 85A(2)(a) of the Act; and
(ii) for a purpose for which the maximum number of repeats specified in the column headed ‘Maximum number of repeats’ specified in the same table item in Schedule 1 for the pharmaceutical benefit was determined under paragraph 85A(2)(b) of the Act; and
(c) if the pharmaceutical benefit is supplied as referred to in subparagraph (a)(ii)—the quantity or number of units of the pharmaceutical benefit supplied to the person must be a quantity or number of units specified for the pharmaceutical item in the pharmaceutical benefit in an item in Schedule 1; and
(d) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 1 for the benefit.